plerixafor

Generic: plerixafor

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name plerixafor
Generic Name plerixafor
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

plerixafor 24 mg/1.2mL

Manufacturer
Fresenius Kabi Usa, LLC

Identifiers & Regulatory

Product NDC 65219-284
Product ID 65219-284_ba468eca-fb47-497b-8aed-a1576249ea6a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA022311
Listing Expiration 2026-12-31
Marketing Start 2023-06-22

Pharmacologic Class

Established (EPC)
hematopoietic stem cell mobilizer [epc]
Physiologic Effect
increased hematopoietic stem cell mobilization [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65219284
Hyphenated Format 65219-284

Supplemental Identifiers

RxCUI
828700
UNII
S915P5499N
NUI
N0000178326 N0000178324

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name plerixafor (source: ndc)
Generic Name plerixafor (source: ndc)
Application Number NDA022311 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 24 mg/1.2mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (65219-284-12) / 1.2 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (1)

65219-284-12 1 VIAL, SINGLE-USE in 1 CARTON (65219-284-12) / 1.2 mL in 1 VIAL, SINGLE-USE

Ingredients (1)

plerixafor (24 mg/1.2mL)

Linked Drug Pages (1)

Plerixafor ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "ba468eca-fb47-497b-8aed-a1576249ea6a", "openfda": {"nui": ["N0000178326", "N0000178324"], "unii": ["S915P5499N"], "rxcui": ["828700"], "spl_set_id": ["5d670cb4-163e-498c-b5fa-c193ea9d55c0"], "pharm_class_pe": ["Increased Hematopoietic Stem Cell Mobilization [PE]"], "pharm_class_epc": ["Hematopoietic Stem Cell Mobilizer [EPC]"], "manufacturer_name": ["Fresenius Kabi Usa, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (65219-284-12)  / 1.2 mL in 1 VIAL, SINGLE-USE", "package_ndc": "65219-284-12", "marketing_start_date": "20230622"}], "brand_name": "Plerixafor", "product_id": "65219-284_ba468eca-fb47-497b-8aed-a1576249ea6a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Hematopoietic Stem Cell Mobilizer [EPC]", "Increased Hematopoietic Stem Cell Mobilization [PE]"], "product_ndc": "65219-284", "generic_name": "PLERIXAFOR", "labeler_name": "Fresenius Kabi Usa, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Plerixafor", "active_ingredients": [{"name": "PLERIXAFOR", "strength": "24 mg/1.2mL"}], "application_number": "NDA022311", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20230622", "listing_expiration_date": "20261231"}